For example, it is revealed that circRNA-MYLK functions as a ceRNA for miR-29a, thus boosting VEGF/VEGFR2 expressions and activating downstream Ras/ERK signaling pathway in bladder cancer progression (Zhong et al., 2017). This evidence concerns the gene MYLK and urinary bladder carcinoma.